- Home
- SPRY vs BHRB Comparison
SPRY vs BHRB Comparison
Compare SPRY & BHRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SPRY | BHRB |
|---|---|---|
| Founded | 2015 | 1852 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 969.2M | 968.8M |
| IPO Year | 2020 | 2023 |
Fundamental Metrics
Financial Performance| Metric | SPRY | BHRB |
|---|---|---|
| Price | $8.54 | $69.84 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 5 |
| Target Price | $40.00 | ★ $71.80 |
| AVG Volume (30 Days) | ★ 1.7M | 189.1K |
| Earning Date | 05-11-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 3.46% |
| EPS Growth | N/A | ★ 173.76 |
| EPS | N/A | ★ 1.79 |
| Revenue | ★ $84,278,000.00 | N/A |
| Revenue This Year | $87.40 | $36.62 |
| Revenue Next Year | $81.64 | $10.06 |
| P/E Ratio | ★ N/A | $38.93 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.66 | $56.35 |
| 52 Week High | $18.63 | $70.90 |
Technical Indicators
Market Signals| Indicator | SPRY | BHRB |
|---|---|---|
| Relative Strength Index (RSI) | 44.56 | 71.50 |
| Support Level | $8.50 | $61.32 |
| Resistance Level | $8.61 | $70.71 |
| Average True Range (ATR) | 0.62 | 1.42 |
| MACD | -0.13 | 0.42 |
| Stochastic Oscillator | 30.86 | 89.32 |
Price Performance
Historical ComparisonAbout SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the commercialization and development of neffy (currently identified in the European Union (EU) and United Kingdom (U.K.) by the trade name EURneffy and in China) for needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. Neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows Neffy to safely provide intranasal delivery of epinephrine at a low dose within the exposures of approved injectable products across a range of dosing conditions.
About BHRB Burke & Herbert Financial Services Corp.
Burke & Herbert Financial Services Corp is the bank holding company. Through its subsidiary, it predominantly serves small to medium-sized businesses, their owners and employees, professional corporations, non-profits, and individuals with various banking products and financial services. Some of its products and service offerings include checking, savings, and money market accounts, certificates of deposit, treasury and cash management services, commercial and industrial loans, commercial real estate loans, residential mortgage, acquisition, construction, and development loans, online banking, mobile banking, and wealth and trust services. The company operates in a single segment, namely Community Banking.